The emerging role of atypical pathogens in community-acquired pneumonia (Q37872805)

24 August 2017

The emerging role of atypical pathogens in community-acquired pneumonia (English)

1 reference

24 August 2017

0 references

Patrick P Gleason

1

1 reference

PubMed ID

11791627

24 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

24 August 2017

1 reference

24 August 2017

22

1 reference

24 August 2017

2S-11S; discussion 30S-32S

1 reference

24 August 2017

1 Pt 2

1 reference

Epidemiology of lower respiratory tract infections

24 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Atypical pathogens in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Community-acquired pneumonia. A prospective outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Microbial aetiology of community-acquired pneumonia in hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

The epidemiology of community-acquired pneumonia among hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Severe community-acquired pneumonia caused by atypical organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Antibiotic resistance: where do ketolides fit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

21 January 2018

Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.2.2S.33130

10.1592/PHCO.22.2.2S.33130

21 January 2018

Identifiers

DOI

1 reference

release_kbvsojzpundafavzmijtw3tjma

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kbvsojzpundafavzmijtw3tjma

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

11791627

1 reference

PubMed ID

11791627